litlas
Log inCreate account

Yu Shyr

Active 1975–2025

269
Papers
48,117
Citations
115
h-index
242
i10-index

Citations

Citations per year for Yu Shyr1971: 1 citations1975: 1 citations1984: 1 citations1994: 2 citations1995: 8 citations1996: 36 citations1997: 40 citations1998: 61 citations1999: 86 citations2000: 103 citations2001: 135 citations2002: 157 citations2003: 169 citations2004: 196 citations2005: 251 citations2006: 268 citations2007: 277 citations2008: 270 citations2009: 286 citations2010: 272 citations2011: 308 citations2012: 417 citations2013: 455 citations2014: 518 citations2015: 541 citations2016: 533 citations2017: 539 citations2018: 537 citations2019: 1,598 citations2020: 1,920 citations2021: 1,855 citations2022: 1,310 citations2023: 913 citations2024: 1,342 citations2025: 616 citations2026: 25 citations1972–1974: no citations, so these years are not shown1976–1983: no citations, so these years are not shown1985–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,135 citing papers, 30.3% of this breakdownChina: 2,485 citing papers, 10.6% of this breakdownUnited Kingdom: 1,412 citing papers, 6% of this breakdownItaly: 1,182 citing papers, 5% of this breakdownGermany: 1,047 citing papers, 4.5% of this breakdownFrance: 783 citing papers, 3.3% of this breakdownCanada: 729 citing papers, 3.1% of this breakdownAustralia: 651 citing papers, 2.8% of this breakdownJapan: 644 citing papers, 2.7% of this breakdownSpain: 614 citing papers, 2.6% of this breakdownNetherlands: 566 citing papers, 2.4% of this breakdownSwitzerland: 447 citing papers, 1.9% of this breakdown
0%30.3%Other 24.8%

Institutions

Fields

  • Medicine52.8%
  • Biochemistry, Genetics and Molecular Biology31.2%
  • Immunology and Microbiology5.1%
  • Nursing1.8%
  • Chemistry1.5%
  • Computer Science1.3%
  • Other6.3%

Topics

  • Cancer Immunotherapy and Biomarkers3.1%
  • Cancer Genomics and Diagnostics2.4%
  • Cancer Cells and Metastasis2.3%
  • Lung Cancer Treatments and Mutations2.1%
  • Breast Cancer Treatment Studies1.9%
  • Advanced Breast Cancer Therapies1.5%
  • Other86.7%

Coauthors

All papers

Open in search
  1. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

    Authors: Brian D. Lehmann, Joshua A. Bauer, Xi Chen, Melinda E. Sanders, A. Bapsi Chakravarthy, Yu Shyr, Jennifer A. Pietenpol - Journal of Clinical Investigation 2011 cited by 5,515

  2. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

    Authors: Brian D. Lehmann, Bojana Jovanović, Xi Chen, Mónica V. Estrada, Kimberly N. Johnson, Yu Shyr, Harold L. Moses, Melinda E. Sanders, Jennifer A. Pietenpol - PLoS ONE 2016 cited by 1,409

  3. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

    Authors: Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado, Violeta Sánchez, Deon B. Doxie, Susan R. Opalenik, Anna E. Vilgelm, Emily Feld, Adam S. Johnson, Allison R. Greenplate, Melinda E. Sanders, Christine M. Lovly, Dennie T. Frederick, Mark C. Kelley, Ann Richmond, Jonathan M. Irish, Yu Shyr, Ryan J. Sullivan, Igor Puzanov, Jeffrey A. Sosman, Justin M. Balko - Nature Communications 2016 cited by 572

  4. Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Authors: Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, David J. Kwiatkowski, A. John Iafrate, Ignacio I. Wistuba, Marileila Varella‐Garcia, Wilbur A. Franklin, Samuel L. Aronson, Pei-Fang Su, Yu Shyr, D. Ross Camidge, Lecia V. Sequist, Bonnie S. Glisson, Fadlo R. Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, Mark A. Socinski, Keisuke Shirai, Heidi Chen, Giuseppe Giaccone, Marc Ladanyi, Kelly Kugler, John D. Minna, Paul A. Bunn - JAMA 2014 cited by 1,744

  5. Integrated Omics of Metastatic Colorectal Cancer

    Authors: Chen Li, Yidi Sun, Guanyu Yu, Jing-Ru Cui, Zheng Lou, Hang Zhang, Ya Huang, Chen-Guang Bai, Lu-Lu Deng, Peng Liu, Kuo Zheng, Yan-Hua Wang, Qin-Qin Wang, Qingrun Li, Qingqing Wu, Qi Liu, Yu Shyr, Yi-Xue Li, Luo-Nan Chen, Jia-Rui Wu, Wei Zhang, Rong Zeng - Cancer Cell 2020 cited by 304

  6. DC isoketal-modified proteins activate T cells and promote hypertension

    Authors: Annet Kirabo, Vanessa Fontana, Ana Paula de Faria, Roxana Loperena, Cristi L. Galindo, Jing Wu, Alfiya Bikineyeva, Sergey Dikalov, Liang Xiao, Wei Chen, Mohamed A. Saleh, Daniel W. Trott, Hana A. Itani, Antony Vinh, Venkataraman Amarnath, Kalyani Amarnath, Tomasz J. Guzik, Kenneth E. Bernstein, Xiao Z. Shen, Yu Shyr, Sheau‐Chiann Chen, Raymond L. Mernaugh, Cheryl L. Laffer, Fernando Elijovich, Sean S. Davies, Heitor Moreno, Meena S. Madhur, Jackson Roberts, David G. Harrison - Journal of Clinical Investigation 2014 cited by 533

  7. Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

    Authors: Luigi Formisano, Yao Lu, Alberto Servetto, Ariella B. Hanker, Valerie M. Jansen, Joshua A. Bauer, Dhivya R. Sudhan, Ángel Guerrero‐Zotano, Sarah Croessmann, Yan Guo, Paula I. González-Ericsson, Kyung‐min Lee, Mellissa J. Nixon, Luis J. Schwarz, Melinda E. Sanders, Teresa C. Dugger, Marcelo Cruz, Amir Behdad, Massimo Cristofanilli, Aditya Bardia, Joyce O’Shaughnessy, Rebecca J. Nagy, Richard B. Lanman, Nadia Solovieff, Wei He, Michelle C. Miller, Fei Su, Yu Shyr, Ingrid A. Mayer, Justin M. Balko, Carlos L. Arteaga - Nature Communications 2019 cited by 419

  8. Biomarker Discovery and Validation: Statistical Considerations

    Authors: Fang‐Shu Ou, Stefan Michiels, Yu Shyr, Alex A. Adjei, Ann L. Oberg - Journal of Thoracic Oncology 2021 cited by 232

  9. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

    Authors: Yang Li, Laura M. DeBusk, Koari Fukuda, Barbara Fingleton, Brenda Green‐Jarvis, Yu Shyr, Lynn M. Matrisian, David P. Carbone, P. Charles Lin - Cancer Cell 2004 cited by 1,136

  10. Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib

    Authors: Jeffrey A. Sosman, Kevin B. Kim, Lynn M. Schuchter, René González, Anna C. Pavlick, Jeffrey S. Weber, Grant A. McArthur, Thomas E. Hutson, Stergios J. Moschos, Keith T. Flaherty, Peter Hersey, Richard Kefford, Donald P. Lawrence, Igor Puzanov, Karl D. Lewis, Ravi K. Amaravadi, Bartosz Chmielowski, H. Jeffrey Lawrence, Yu Shyr, Fei Ye, Jiang Li, K. B. Nolop, Richard J. Lee, Andrew K. Joe, Antoni Ribas - New England Journal of Medicine 2012 cited by 2,148

  11. Preoperative and Postoperative Systemic Therapy for Operable Non–Small-Cell Lung Cancer

    Authors: Jamie E. Chaft, Yu Shyr, Boris Sepesi, Patrick M. Forde - Journal of Clinical Oncology 2022 cited by 210

  12. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer

    Authors: Todd W. Miller, Bryan T. Hennessy, Ana M. González-Angulo, Emily M. Fox, Gordon B. Mills, Heidi Chen, Catherine Higham, Carlos Garcı́a-Echeverrı́a, Yu Shyr, Carlos L. Arteaga - Journal of Clinical Investigation 2010 cited by 545

  13. Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse

    Authors: Karinna Almodovar, Wade T. Iams, Catherine B. Meador, Zhiguo Zhao, Sally J. York, Leora Horn, Yingjun Yan, Jennifer Hernandez, Heidi Chen, Yu Shyr, Lee P. Lim, Christopher K. Raymond, Christine M. Lovly - Journal of Thoracic Oncology 2017 cited by 137

  14. The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor

    Authors: Anne E. Powell, Yang Wang, Yina Li, Emily J. Poulin, Anna L. Means, Mary K. Washington, James N. Higginbotham, Alwin M. Juchheim, Nripesh Prasad, Shawn Levy, Yan Guo, Yu Shyr, Bruce J. Aronow, Kevin M. Haigis, Jeffrey L. Franklin, Robert J. Coffey - Cell 2012 cited by 694

  15. Nationwide Trends in Mastectomy for Early-Stage Breast Cancer

    Authors: Kristy L. Kummerow, Liping Du, David F. Penson, Yu Shyr, Mary Hooks - JAMA Surgery 2014 cited by 727

  16. TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer

    Authors: Brian D. Lehmann, Vandana G. Abramson, Melinda E. Sanders, Erica L. Mayer, Tufia C. Haddad, Rita Nanda, Catherine Van Poznak, Anna Maria Storniolo, Julie R. Nangia, Paula I. González-Ericsson, Violeta Sánchez, Kimberly N. Johnson, Richard G. Abramson, Sheau‐Chiann Chen, Yu Shyr, Carlos L. Arteaga, Antonio C. Wolff, Jennifer A. Pietenpol - Clinical Cancer Research 2019 cited by 154

  17. Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer

    Authors: J. Joshua Smith, Natasha G. Deane, Fei Wu, Nipun B. Merchant, Bing Zhang, Aixiang Jiang, Pengcheng Lu, James C. Johnson, Carl Schmidt, Christina E. Bailey, Steven A. Eschrich, Christian Kis, Shawn Levy, M. Kay Washington, Martin J. Heslin, Robert J. Coffey, Timothy J. Yeatman, Yu Shyr, R. Daniel Beauchamp - Gastroenterology 2009 cited by 730

  18. Improvements and impacts of GRCh38 human reference on high throughput sequencing data analysis

    Authors: Yan Guo, Yulin Dai, Hui Yu, Shilin Zhao, David C. Samuels, Yu Shyr - Genomics 2017 cited by 182

  19. Oligoclonal CD8 + T Cells Play a Critical Role in the Development of Hypertension

    Authors: Daniel W. Trott, Salim Thabet, Annet Kirabo, Mohamed A. Saleh, Hana A. Itani, Allison E. Norlander, Jing Wu, Anna E. Goldstein, William J. Arendshorst, Meena S. Madhur, Wei Chen, Chung-I Li, Yu Shyr, David G. Harrison - Hypertension 2014 cited by 236

  20. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

    Authors: Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera, Sanjay Shete, Chih–Yuan Hsu, Aakash Desai, Gilberto Lopes, Petros Grivas, Corrie Painter, Solange Peters, Michael A Thompson, Ziad Bakouny, Gerald Batist, Tanios Bekaii‐Saab, Mehmet Asım Bilen, Nathaniel Bouganim, Mateo Bover Larroya, Daniel Castellano, Salvatore A. Del Prete, Deborah B. Doroshow, Pamela Egan, Arielle Elkrief, Dimitrios Farmakiotis, Daniel Flora, Matthew D. Galsky, Michael Glover, Elizabeth A. Griffiths, Anthony P. Gulati, Shilpa Gupta, Navid Hafez, Þorvarður R. Hálfdánarson, Jessica E. Hawley, Emily Hsu, Anup Kasi, Ali Raza Khaki, Christopher A. Lemmon, Colleen Lewis, Barbara Logan, Tyler Masters, Rana R. McKay, Ruben A. Mesa, Alicia K. Morgans, Mary F. Mulcahy, Orestis A. Panagiotou, Prakash Peddi, Nathan A. Pennell, Kerry L. Reynolds, L Rosen, Rachel Rosovsky, Mary Salazar, Andrew Schmidt, Sumit Shah, Justin Shaya, John A. Steinharter, Keith Stockerl‐Goldstein, Suki Subbiah, Donald C. Vinh, Firas Wehbe, Lisa B. Weissmann, Julie Wu, Elizabeth Wulff‐Burchfield, Zhuoer Xie, Albert C. Yeh, Peter Paul Yu, Alice Y. Zhou, Leyre Zubiri, Sanjay Mishra, Gary H. Lyman, Brian I. Rini, Jeremy L. Warner, Maheen Z. Abidi, Jared D. Acoba, Neeraj Agarwal, Syed A. Ahmad, Archana Ajmera, Jessica K. Altman, Anne H. Angevine, Nilo Azad, Michael Bär, Aditya Bardia, Jill S. Barnholtz‐Sloan, Briana Barrow, Babar Bashir, Rimma Belenkaya, Stephanie Berg, Eric Bernicker, Christine M. Bestvina, Rohit Bishnoi, Genevieve M. Boland, Mark Bonnen, Gabrielle Bouchard, Daniel W. Bowles, Fiona Busser, Angelo Cabal, Paolo F. Caimi, Theresa M. Carducci, Carla Casulo and 136 more - The Lancet 2020 cited by 1,802

  21. Advanced Heat Map and Clustering Analysis Using Heatmap3

    Authors: Shilin Zhao, Yan Guo, Quanhu Sheng, Yu Shyr - BioMed Research International 2014 cited by 352

  22. Genomic profiling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance

    Authors: Jennifer M. Giltnane, Katherine E. Hutchinson, Thomas Stricker, Luigi Formisano, Christian D. Young, Mónica V. Estrada, Mellissa J. Nixon, Liping Du, Violeta Sánchez, Paula I. González-Ericsson, María G. Kuba, Melinda E. Sanders, Xinmeng Jasmine Mu, Eliezer M. Van Allen, Nikhil Wagle, Ingrid A. Mayer, Vandana G. Abramson, Henry Gómez, Monica Rizzo, Weiyi Toy, Sarat Chandarlapaty, Erica L. Mayer, Jason Christiansen, Danielle Murphy, Kerry Fitzgerald, Kai Wang, Jeffrey S. Ross, Vincent A. Miller, P. J. Stephens, Roman Yelensky, Levi A. Garraway, Yu Shyr, Ingrid M. Meszoely, Justin M. Balko, Carlos L. Arteaga - Science Translational Medicine 2017 cited by 124

  23. Plasma cytokine levels predict mortality in patients with acute renal failure

    Authors: Edith Simmons, Jonathan Himmelfarb, Mehmet Tuğrul Sezer, Glenn M. Chertow, Ravindra L. Mehta, Emil P. Paganini, Sharon Soroko, S. Freedman, Karen Becker, Daniel Spratt, Yu Shyr, Talp Ikizler, for the PICARD Study Group - Kidney International 2004 cited by 444

  24. Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis

    Authors: Alexander Gelbard, Catherine Anderson, Lynne D. Berry, Milan R. Amin, Michael S. Benninger, Joel H. Blumin, Jonathan M. Bock, Paul C. Bryson, Paul F. Castellanos, Sheau‐Chiann Chen, Matthew S. Clary, Seth M. Cohen, Brianna K. Crawley, Seth H. Dailey, James J. Daniero, Alessandro de Alarcón, Donald T. Donovan, Eric S. Edell, Dale C. Ekbom, Sara Fernandes‐Taylor, Daniel S. Fink, Ramon A. Franco, C. Gaelyn Garrett, Elizabeth Guardiani, Alexander T. Hillel, Henry T. Hoffman, Norman D. Hogikyan, Rebecca J. Howell, Li‐Ching Huang, Lena K. Hussain, Michael M. Johns, Jan L. Kasperbauer, Sid Khosla, Cheryl Kinnard, Robbi A. Kupfer, Alexander Langerman, Robert J. Lentz, Robert R. Lorenz, David G. Lott, Anne S. Lowery, Samir Makani, Fabien Maldonado, Kyle Mannion, Laura Matrka, Andrew J. McWhorter, Albert L. Meratı, Matthew Mori, James L. Netterville, Karla O’Dell, Julina Ongkasuwan, Gregory N. Postma, Lindsay Reder, Sarah L. Rohde, Brent E. Richardson, Otis B. Rickman, Clark A. Rosen, Michael J. Rutter, Guri Sandhu, Joshua S. Schindler, Glenn Todd Schneider, Rupali N. Shah, Andrew G. Sikora, Robert J. Sinard, Marshall E. Smith, Libby J. Smith, Ahmed M. S. Soliman, Sigríður Sveinsdóttir, Douglas J. Van Daele, David Veivers, Sunil P. Verma, Paul Weinberger, Philip A. Weissbrod, Christopher T. Wootten, Yu Shyr, David O. Francis - JAMA Otolaryngology–Head & Neck Surgery 2019 cited by 165